Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2015 Sep 18;142(3):549–560. doi: 10.1007/s00432-015-2047-6

Figure 8. Proposed illustration of protein degradation pathways in lung cancer cells.

Figure 8

(a). Untreated cells utilize two intracellular catabolic pathways for the removal of misfolded proteins. (b). As CFZ blocks the ubiquitin proteasome system, resistant cells degrade misfolded proteins through increased use of the autophagy-lysosome pathway. (c). Blocking the two major degradation pathways with CFZ + SAHA treatment results in the accumulation of misfolded proteins, ER stress, and cell death.